Testosterone deficiency and non-alcoholic fatty liver disease in men with type 2 diabetes mellitus

BACKGROUND: Current studies investigated diseases associated with testosterone (T) deficiency; however, data on the combination of non-alcoholic fatty liver disease (NAFLD) with hypogonadism and diabetes mellitus (DM) in men are extremely limited. AIMS: To evaluate the effects of hypogonadism on th...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Irina A. Khripun, Sergey V. Vorobyev, Yanina Allahverdieva
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2019
Materias:	hypogonadism testosterone diabetes mellitus nonalcoholic fatty liver disease liver androgen deficiency Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/dec8d163fa594190bd6648a631d7058a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:dec8d163fa594190bd6648a631d7058a
record_format	dspace
spelling	oai:doaj.org-article:dec8d163fa594190bd6648a631d7058a2021-11-14T09:00:22ZTestosterone deficiency and non-alcoholic fatty liver disease in men with type 2 diabetes mellitus2072-03512072-037810.14341/DM10232https://doaj.org/article/dec8d163fa594190bd6648a631d7058a2019-12-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/10232https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378BACKGROUND: Current studies investigated diseases associated with testosterone (T) deficiency; however, data on the combination of non-alcoholic fatty liver disease (NAFLD) with hypogonadism and diabetes mellitus (DM) in men are extremely limited. AIMS: To evaluate the effects of hypogonadism on the formation and progression of NAFLD in men with type 2 DM. METHODS: The study included 90 men with type 2 DM [age 54 (49–57) years]. Patients underwent clinical examinations, biochemical analysis (alanine aminotransferase (ALT), aspartate aminotransferase, gamma-glutamyl transpeptidase (GGTP), fasting glucose, immunoreactive insulin, HOMA index, HbA1c, lipid profile), immune enzyme analysis (luteinising hormone, total T, sex hormone binding globulin, resistin, adiponectin, leptin) and magnetic resonance imaging with liver fat fraction determination were performed. Patients were divided into two groups: 1–32 eugonadal patients and 2–58 men with newly diagnosed hypogonadism. RESULTS: Increased insulin resistance, hyperinsulinemia, hypertriglyceridemia were observed in men with hypogonadism compared to eugonadal patients. Along with biochemical signs of impaired liver function, such as an increase in liver enzyme concentrations of ALT by 24.5% (p = 0.02), GGTP by 60.5% (p = 0.001), de Rytis coefficient by 60.4% (p = 0.047), of men in the 2nd group, the liver fat fraction also increased, which together indicates NAFLD progression. The proton density of the liver fat fraction according to MRI was 4.12 [2.25–5.30] % in the 1st group and 10.30 [7.78; 14.44] % in the 2nd group (p=0.001). This was accompanied by an increase in fat production of resistin by 2 times and leptin by 12 times (p <0.001) in patients of group 2 compared to 1. CONCLUSIONS: The combination of type 2 DM with hypogonadism in men leads not only to deterioration of carbohydrate and lipid metabolism but also to disturbance of liver function: increased ALT, GGTP concentrations and liver fat. Increased secretion of leptin and resistin in the adipose tissue is assumed to be a pathogenetically associated with the development of carbohydrate and lipid metabolism disorders, NAFLD and T deficiency.Irina A. KhripunSergey V. VorobyevYanina AllahverdievaEndocrinology Research Centrearticlehypogonadismtestosteronediabetes mellitusnonalcoholic fatty liver diseaseliverandrogen deficiencyNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 22, Iss 6, Pp 542-549 (2019)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	hypogonadism testosterone diabetes mellitus nonalcoholic fatty liver disease liver androgen deficiency Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	hypogonadism testosterone diabetes mellitus nonalcoholic fatty liver disease liver androgen deficiency Nutritional diseases. Deficiency diseases RC620-627 Irina A. Khripun Sergey V. Vorobyev Yanina Allahverdieva Testosterone deficiency and non-alcoholic fatty liver disease in men with type 2 diabetes mellitus
description	BACKGROUND: Current studies investigated diseases associated with testosterone (T) deficiency; however, data on the combination of non-alcoholic fatty liver disease (NAFLD) with hypogonadism and diabetes mellitus (DM) in men are extremely limited. AIMS: To evaluate the effects of hypogonadism on the formation and progression of NAFLD in men with type 2 DM. METHODS: The study included 90 men with type 2 DM [age 54 (49–57) years]. Patients underwent clinical examinations, biochemical analysis (alanine aminotransferase (ALT), aspartate aminotransferase, gamma-glutamyl transpeptidase (GGTP), fasting glucose, immunoreactive insulin, HOMA index, HbA1c, lipid profile), immune enzyme analysis (luteinising hormone, total T, sex hormone binding globulin, resistin, adiponectin, leptin) and magnetic resonance imaging with liver fat fraction determination were performed. Patients were divided into two groups: 1–32 eugonadal patients and 2–58 men with newly diagnosed hypogonadism. RESULTS: Increased insulin resistance, hyperinsulinemia, hypertriglyceridemia were observed in men with hypogonadism compared to eugonadal patients. Along with biochemical signs of impaired liver function, such as an increase in liver enzyme concentrations of ALT by 24.5% (p = 0.02), GGTP by 60.5% (p = 0.001), de Rytis coefficient by 60.4% (p = 0.047), of men in the 2nd group, the liver fat fraction also increased, which together indicates NAFLD progression. The proton density of the liver fat fraction according to MRI was 4.12 [2.25–5.30] % in the 1st group and 10.30 [7.78; 14.44] % in the 2nd group (p=0.001). This was accompanied by an increase in fat production of resistin by 2 times and leptin by 12 times (p <0.001) in patients of group 2 compared to 1. CONCLUSIONS: The combination of type 2 DM with hypogonadism in men leads not only to deterioration of carbohydrate and lipid metabolism but also to disturbance of liver function: increased ALT, GGTP concentrations and liver fat. Increased secretion of leptin and resistin in the adipose tissue is assumed to be a pathogenetically associated with the development of carbohydrate and lipid metabolism disorders, NAFLD and T deficiency.
format	article
author	Irina A. Khripun Sergey V. Vorobyev Yanina Allahverdieva
author_facet	Irina A. Khripun Sergey V. Vorobyev Yanina Allahverdieva
author_sort	Irina A. Khripun
title	Testosterone deficiency and non-alcoholic fatty liver disease in men with type 2 diabetes mellitus
title_short	Testosterone deficiency and non-alcoholic fatty liver disease in men with type 2 diabetes mellitus
title_full	Testosterone deficiency and non-alcoholic fatty liver disease in men with type 2 diabetes mellitus
title_fullStr	Testosterone deficiency and non-alcoholic fatty liver disease in men with type 2 diabetes mellitus
title_full_unstemmed	Testosterone deficiency and non-alcoholic fatty liver disease in men with type 2 diabetes mellitus
title_sort	testosterone deficiency and non-alcoholic fatty liver disease in men with type 2 diabetes mellitus
publisher	Endocrinology Research Centre
publishDate	2019
url	https://doaj.org/article/dec8d163fa594190bd6648a631d7058a
work_keys_str_mv	AT irinaakhripun testosteronedeficiencyandnonalcoholicfattyliverdiseaseinmenwithtype2diabetesmellitus AT sergeyvvorobyev testosteronedeficiencyandnonalcoholicfattyliverdiseaseinmenwithtype2diabetesmellitus AT yaninaallahverdieva testosteronedeficiencyandnonalcoholicfattyliverdiseaseinmenwithtype2diabetesmellitus
_version_	1718429495605592064

Testosterone deficiency and non-alcoholic fatty liver disease in men with type 2 diabetes mellitus

Ejemplares similares